• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

  • About
    • General Information
    • Disease Research
    • Training & Outreach
    • Events
    • Careers
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • News Releases
    • Publications
    • On Your Health
    • Bodywork
  • Patients
    • Anti Aging Study
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Disease
    • Osteoarthritis
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Ways to Give
    • Tax Credit
    • Planned Giving
    • Contact Philanthropy
Home - News - “Bench to Bedside” Series to Show How Scientific Research Benefits Humankind

“Bench to Bedside” Series to Show How Scientific Research Benefits Humankind

September 8, 1998

“From Bench to Bedside: Biomedicine at the New Millenium,” a series of free public lectures this fall sponsored by the Oklahoma Medical Research Foundation, will feature nationally and internationally recognized OMRF scientists and physicians presenting the lastest research being done on a number of high profile diseases and conditions.

“These exciting and informative programs are designed to explain, in easily understandable terms, how scientific bench research translates into new and more effective drugs, treatments and procedures for the most serious diseases of our time,” said J.Donald Capra, M.D., OMRF president and scientific director.

Four lectures are scheduled for the fall series. “The Dynamic Future of Vaccines: Charting New Territory,” will be presented by Capra on September 24. He will discuss the newer, available vaccines such as those for hepatitis, as well as current research and future vaccines for cancer, heart disease, lupus, and stroke.

“Lupus & Arthritis: What Role Genetics Play,” will be presented by John Harley, M.D., Ph.D., October 8. He will explore these autoimmune diseases, plus others, which are generated either by something in the environment or in a person’s genes.

Robert Floyd, Ph.D., head of the Free Radical Biology & Aging Research Program, will present “Alzheimer’s, Parkinson’s and Stroke: A New Discovery, A New Hope,” on October 20. Floyd will present information on discoveries made at OMRF that have led to the commercial development of a new class of drugs that show promise to treat not only stroke but Alzheimer’s and Parkinson’s diseases as well.

“The Heart of the Matter: The Latest Findings in Cardiovascular Disease,” by Charles Esmon, Ph.D., will conclude the fall series November 10. Esmon is head of the Cardiovascular Biology Research Program. He will explain how the cardiovascular system encompasses much more than just the heart, and how blood vessels provide a battle front against stroke, phlebitis, septic shock, cancer and heart attack.

All lectures will be in the Wileman Learning Center at OMRF, 825 N.E. 13th Street, at 7:00 p.m. They will be approximately one hour, which includes a question and answer period. Reservations are encouraged but not essential, as there is limited seating. Call 271-7218 for more information or to reserve a seat. Ample parking and security is provided; refreshments will be served.

Filed Under: News Tagged With: Charles, Esmon, scientist-news

Before Footer

Equal Opportunity Employer

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Ethics Point
  • Intranet
Facebook Twitter Instagram Linkedin

Subscribe to OMRF News
  • Contact
  • Careers
  • Donor Privacy
  • Ethics Point
  • Intranet
OMRF Logo
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13th St.
Oklahoma City, OK 73104
(405) 271-6673
Charity navigatorUnited WayTop Workplace